Merkel cell carcinoma

Emma Ramahi, Jehee Choi, Clifton D. Fuller, Tony Y. Eng

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations

Abstract

Merkel cell carcinoma (MCC) is a rare, clinically aggressive cutaneous neuroendocrine neoplasm with a high mortality rate. Though the etiology is not precisely known, Merkel cell polyomavirus DNA has been found recently in a large percentage of MCC tumors. Other suggested risk factors include sun exposure, immunosuppression, and a history of prior malignancy. Work up of patients with MCC most notably includes nodal staging via clinical examination or sentinel lymph node biopsy. The prognosis for most patients with MCC is poor, and the rarity of MCC precludes the prospective, randomized clinical trials necessary to elucidate optimum treatment protocols. Most published data support the use of a multimodality approach centered around surgical excision with negative margins, sentinel lymph node biopsy to establish the presence or absence of nodal metastases, adjuvant radiothearpy to decrease the risk of recurrence, and systemic chemotherapy in the case of widespread disease.

Original languageEnglish (US)
Pages (from-to)299-309
Number of pages11
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume36
Issue number3
DOIs
StatePublished - Jun 2013

Keywords

  • Merkel cell carcinoma
  • chemotherapy
  • etiology
  • imaging
  • radiation therapy
  • surgery

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Merkel cell carcinoma'. Together they form a unique fingerprint.

Cite this